Blog

The recent announcement from The University of Texas MD Anderson Cancer Center regarding groundbreaking research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting is a...

The recent findings presented by researchers from Roswell Park Comprehensive Cancer Center at the American Society of Clinical Oncology (ASCO) annual meeting highlight significant strides in cancer...

The landscape of cancer research is continually evolving, driven by the dedication and innovation of those entering the field. A recent initiative at the University of Chicago, the Scholars in...

In the ever-evolving field of oncology, the need for innovative thinking and fresh perspectives is more crucial than ever. A recent initiative from the University of Chicago, known as the Scholars in...

The landscape of cancer treatment is continually evolving, and major events like the ASCO Annual Meeting provide critical platforms for sharing groundbreaking discoveries. This year, from May 29 to...

The annual ASCO meeting is a pivotal event in the oncology calendar, where advancements in cancer research and treatment are showcased to a global audience. This year, the University of Chicago...

The recent announcement from The University of Texas MD Anderson Cancer Center about emerging precision therapies for rare and difficult-to-treat cancers is a significant milestone in the realm of...

The landscape of cancer treatment is constantly evolving, and recent developments by researchers at the Dana-Farber Cancer Institute promise to significantly impact how various cancers are approached...

At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO), researchers from the Dana-Farber Cancer Institute presented groundbreaking findings that could redefine treatment...

As the annual meeting of the American Society of Clinical Oncology (ASCO) approaches, the Fred Hutch Cancer Center is poised to share groundbreaking advancements in the treatment of various cancers,...

At the recent ASCO 2026 conference, groundbreaking research emerged that could significantly change the way we understand and treat solitary fibrous tumors (SFTs). These rare tumors, while often...

Recent research presented at the ASCO 2026 conference sheds light on solitary fibrous tumors (SFTs), a rare type of cancer, highlighting genetic patterns that may predict tumor behavior. Conducted by...

In a groundbreaking study published recently, researchers have unveiled a new biomarker known as HAVCR1 that could transform the early detection and treatment of rare and aggressive brain, spinal...

Recent research published on May 21, 2026, has unveiled a groundbreaking discovery regarding the progression of precancerous lesions in the pancreas, shedding light on how these changes can evolve...

Recent research from the James P. Allison Institute at The University of Texas MD Anderson Cancer Center has unveiled a significant breakthrough in the treatment of metastatic castration-resistant...

In a significant stride toward enhancing our understanding of cancer, the Endocrine Society and Keystone Symposia are set to host their first joint conference in October. This gathering of...

The intersection of hormones and cancer is a critical area of research that is gaining momentum, particularly with the announcement of the first joint conference hosted by the Endocrine Society and...

In a significant boost for cancer research and care, the University of Texas MD Anderson Cancer Center has been awarded over $19 million by the Cancer Prevention and Research Institute of Texas...

In a groundbreaking study, researchers from Stony Brook Medicine and Yale School of Medicine have identified a protein known as K17 as a significant contributor to the resistance of pancreatic cancer...

Recent research led by a team from Stony Brook Medicine and Yale School of Medicine has unveiled a promising target in the ongoing battle against pancreatic cancer: a protein known as K17. This...